Odyssey Therapeutics, Inc. (ODTX)
Price History
May 10, 2026 — Aug 25, 2026Investment Snapshot
- P/B of 1.94 — trading above book value
- Piotroski F-Score 0/9 — signs of financial weakness
- Loss-making — negative ROE of -40.5%
Odyssey Therapeutics, Inc. (ODTX) is a publicly traded company, listed on the NASDAQ , with a market capitalisation of $817 million . Key value metrics: P/B ratio 1.94, Piotroski F-Score 0 out of 9 .
Value Score
Key Metrics
Odyssey Therapeutics, Inc. — Fundamental Analysis Summary
On financial health, ODTX shows a weak Piotroski F-Score of 0/9, a signal of deteriorating financial health, and negative return on equity of -40.5%.
StockPik's composite Value Score for ODTX is 35/100 — reflecting current market or financial concerns. The score is built from ten fundamental signals: P/E, P/B, PEG ratio, P/S ratio, return on equity, gross margin, debt-to-equity, current ratio, dividend yield, and Piotroski F-Score.